P07679 AF NFT

Bowman-Birk type trypsin inhibitor TI1

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiasyp4irxjulxxxw6jactxndw2mcxm33mlrm54joocinbaf7tqzru/metadata.json
IPFS of structure file: 
bafybeihiv6qouvjqyfygxmvebabt2x5zrw4prjrg4g7duieqicpmm7lwhe/AF-P07679-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x1f0b1aeA56C13da54F3c6EE6CE41C19fcF2DD979
First NFT owner address (bech32): 
genesis1ru9346jkcy762neudmnvuswpnl8jmktetllypr
Current NFT ID #183020 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
183020
Accession (UniProt):
P07679
Name::
Bowman-Birk type trypsin inhibitor TI1
Experimental Method:
Predicted structure
Sequence source:
Coix lacryma-jobi

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P07679 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P07679|IBB1_COILA Bowman-Birk type trypsin inhibitor TI1 OS=Coix lacryma-jobi OX=4505 PE=1 SV=1 GDEKRPWECCDIAMCTRSIPPICRCVDKVDRCSDACKDCEETEDNRHVCFDTYIGDPGPTCHDD